Nukkleus Company Leadership

NUKK Stock  USD 2.41  0.03  1.26%   
Nukkleus employs about 15 people. The company is managed by 8 executives with a total tenure of roughly 10 years, averaging almost 1.0 years of service per executive, having 1.88 employees per reported executive. Inspection of Nukkleus' management performance can provide insight into the company performance.
Emil Assentato  CEO
President CEO, Treasurer, Secretary, Director
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Nukkleus Management Team Effectiveness

The company has return on total asset (ROA) of (3.973) % which means that it has lost $3.973 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.4205) %, meaning that it created substantial loss on money invested by shareholders. Nukkleus' management efficiency ratios could be used to measure how well Nukkleus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -9.64 this year. The value of Return On Capital Employed is expected to slide to 2.60. At this time, Nukkleus' Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 957.3 K this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 1.1 M.
The value of Common Stock Shares Outstanding is expected to slide to about 1.9 M. Net Loss is expected to rise to about (10.1 M) this yearNukkleus maintains a total of 25.27 Million outstanding shares. Nukkleus holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2013-12-31
Previous Quarter
5.6 M
Current Value
8.1 M
Avarage Shares Outstanding
117.8 M
Quarterly Volatility
245.8 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Dividends Paid is expected to rise to about 347.6 K this year, although the value of Dividend Yield will most likely fall to 0.0006. The value of Common Stock Shares Outstanding is expected to slide to about 1.9 M. Net Loss is expected to rise to about (10.1 M) this year.

Nukkleus Workforce Comparison

Nukkleus is rated below average in number of employees category among its peers. The total workforce of Information Technology industry is now estimated at about 4,105. Nukkleus adds roughly 15.0 in number of employees claiming only tiny portion of equities under Information Technology industry.

Nukkleus Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nukkleus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nukkleus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nukkleus insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
 
Interest Hikes
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-12-01
0.75
9
12
 3,152,421 
 2,348,808 
2023-12-01
0.5
1
2
 157,500,000 
 204,000,000 
2023-06-01
1.0
1
1
 6,600,000 
 6,600,000 
2021-09-01
2.0
2
1
 11,134,792 
 0.00 

Nukkleus Notable Stakeholders

A Nukkleus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nukkleus often face trade-offs trying to please all of them. Nukkleus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nukkleus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Emil AssentatoPresident CEO, Treasurer, Secretary, DirectorProfile
Menachem ShalomCEO DirectorProfile
David RokachCOO DirectorProfile
Jamal KhurshidCOO DirectorProfile
Yair OhayonInvestor OfficerProfile
Morel LeviChief OfficerProfile
Andrew MBAChief OfficerProfile
Shawn DilkesChief OfficerProfile
String symbol = request.getParameter("s");

About Nukkleus Management Performance

The success or failure of an entity such as Nukkleus often depends on how effective the management is. Nukkleus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nukkleus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nukkleus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(10.14)(9.64)
Return On Capital Employed 2.68  2.60 
Return On Assets(9.95)(9.45)
Return On Equity 1.38  1.31 

Nukkleus Workforce Analysis

Traditionally, organizations such as Nukkleus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nukkleus within its industry.

Nukkleus Manpower Efficiency

Return on Nukkleus Manpower

Revenue Per Employee394.2K
Revenue Per Executive739.1K
Net Loss Per Employee567.9K
Net Loss Per Executive1.1M
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. Anticipated expansion of Nukkleus directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nukkleus assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(4.93)
Revenue Per Share
3.422
Quarterly Revenue Growth
(0.95)
Return On Assets
(3.97)
Return On Equity
(7.42)
Investors evaluate Nukkleus using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nukkleus' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nukkleus' market price to deviate significantly from intrinsic value.
It's important to distinguish between Nukkleus' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nukkleus should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nukkleus' market price signifies the transaction level at which participants voluntarily complete trades.